Shoulder pain, before you agree to a rotator cuff repair.

Rotator cuff degeneration, shoulder osteoarthritis, and chronic impingement frequently respond to MSC therapy when the tendon is thinned but not fully retracted. The evaluation tells you what you're working with.

Medically reviewed by the physician team at Hospital Angeles · October 2026

A Celva physician examining a patient's shoulder during an evaluation

Which rotator cuff tears are a fit, and which need a surgeon?

The shoulder is mostly soft tissue. Cuff thickness, tear size, and tendon retraction determine whether regenerative therapy is reasonable, or whether surgical repair is the right tool. We treat the shoulder as a system: the cuff tendons, the joint surface, and the surrounding soft tissue together, because they fail together.

Illustration of a rotator cuff whose supraspinatus tendon is still attached to the bone but frayed and worn across its surface; an MRI illustration of the same tendon fades in over it
Partial-thickness tear
Illustration of a rotator cuff whose supraspinatus tendon has torn through and pulled back from the bone, leaving the footprint on the humeral head bare; an MRI illustration of the same tear fades in over it
Full-thickness retracted tear

Partial-thickness tears, tendinopathy, and early-stage OA often respond. Full-thickness tears with significant retraction generally do not, once the tendon has pulled away from its footprint, biology alone won't reattach it.

We read your MRI before recommending anything. Our floor isn't "let's try." It's "this is a reasonable case."

  1. Strong fit

    Partial cuff tears, tendinopathy

    Partial-thickness tears, chronic cuff tendinopathy, and refractory impingement.

  2. Also a fit

    Glenohumeral OA, labral drift

    Early to moderate shoulder OA and post-labral-repair residuals.

  3. Not a fit

    Full retracted tears, massive cuff failure

    Full-thickness retracted tears and massive cuff tears where structural reattachment is the only real option.

Shoulder conditions the physician team evaluates.

Rotator cuff tendinopathy, partial tears, glenohumeral OA, and chronic impingement.

Tendon

Rotator cuff

Partial-thickness tears, tendinopathy, and chronic irritation that hasn't resolved with PT or injections.

  • Partial-thickness < 50%
  • Chronic tendinopathy
  • Post-PRP non-responders
Joint

Glenohumeral OA

Early to moderate OA of the GH joint. Late-stage (bone-on-bone) cases are case-by-case if you want to delay a replacement.

  • Early to moderate OA, strongest response
  • Intact glenoid
  • Preserved cuff function
Soft tissue

Impingement & labrum

Chronic subacromial impingement and labral degeneration where conservative care has plateaued.

  • Refractory impingement
  • Labral fraying
  • Post-arthroscopy residuals

Image-guided tendon-targeted delivery.

Shoulder injections require precision against a moving tendon. Every delivery is done under ultrasound or fluoroscopic guidance, with the cells placed at or adjacent to the target structure.

Joint cases like yours use bone-marrow and umbilical-cord MSCs, often in combination and sometimes with chondrocytes for cartilage support. The exact recipe, which cells, what doses, which routes, is decided by Celva's physician team after reviewing your imaging. Matched to your case, not pulled off a shelf. Why we use multiple cell types →

Delivered to the cuff footprint, GH joint, or subacromial space depending on pathology. Procedure runs under local anesthetic, with twilight sedation available if you want it. A comfortable, still patient lets the physician place the cells precisely. Walking and light daily use are fine; protect the shoulder for 7 to 10 days.

  1. MRI review

    Cuff thickness, tear characterization, and joint status evaluated by the physician team.

  2. Target map

    Cuff footprint vs. intra-articular vs. subacromial, matched to pathology.

  3. Image-guided injection

    15 to 30 min · local, sedation optional

    Live needle visualization. Cell release confirmed at target.

  4. Systemic IV

    A second MSC dose in the infusion suite. The IV and the injection are designed to work together.

  5. Check-ins, then once a year

    Your patient coordinator or aftercare specialist follows up for good, not just once: a pain-and-safety call at 1 week, then calls at 1, 3 and 6 months, then once a year, by phone or video. A physician joins when needed. Structured, not reactive.

What to expect. No promises.

Response window
4–12 wks
Shoulder tendon response often tracks slightly faster than large-joint OA.
  1. ~ 2–4 wks

    Settling phase

    Post-injection soreness resolves. Baseline function largely unchanged.

  2. ~ 6–12 wks

    Function returns

    Reach, overhead activity, and sleep typically improve first.

  3. ~ 180 days

    The 6-month review

    Strength and load tolerance are reviewed. Whether a second treatment makes sense is decided at your follow-up reviews.

  4. Through year 1

    Still building

    Improvement can keep building through the first year, with ongoing conditioning.

Shoulder tends to move faster than hip or spine, but the same principle holds: no meaningful change is expected in the first two weeks. What comes back is reach and sleep, read over months, not day-to-day feel.

If your cuff has fully retracted off the footprint or you have a massive tear pattern, MSC therapy will not reattach the tendon. We will refer you to a surgeon we trust when that's the case.

Shoulder-specific questions.

Will MSCs heal a rotator cuff tear?
Partial-thickness tears and chronic tendinopathy often respond. Full-thickness retracted tears generally require surgical repair, biology cannot reattach a tendon that has pulled away from its footprint.
What's the difference between PRP and MSC therapy for shoulder?
PRP delivers concentrated growth factors. MSCs deliver the cells that produce and respond to those signals over longer time frames. For patients who've plateaued on PRP, MSC therapy is the logical next evaluation.
Can I still lift after this?
Yes, often with better tolerance, but not right away. Walking and light daily use are fine; protect the shoulder for the first 7 to 10 days. Physical therapy is recommended after that. Loading and strengthening inside physical therapy are fine; outside it, avoid loading the shoulder for 4 to 6 weeks. Heavy overhead work typically waits until weeks 8 to 12, depending on your baseline.
What about frozen shoulder?
Adhesive capsulitis is not primarily a tendon or cartilage problem. It is a capsular inflammation process, and MSC therapy is not the first-line answer. We'll refer you appropriately.

Start with a read of your MRI.

Your first call is with a Celva patient coordinator; Celva's physician team reads your MRI and tells you plainly whether MSC therapy fits your case, or whether repair is what the structure actually needs.

Book a call →

Not medical advice. Individual results vary. All patients undergo physician screening before treatment is recommended.